News and Trends 6 Mar 2025 Top biotech deals of February 2025 Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations. March 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Mar 2025 Seven biotech companies keeping Taiwan dynamic in 2025 Discover 7 biotech companies in Taiwan, a rising regional player in precision medicine, immunotherapy, and drug development, backed by strong research and government support. March 5, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 4 Mar 2025 The biggest biotech funding rounds in February 2025 The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in February 2025. March 4, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Reports Produced by Inpart 3 Mar 2025R&D trends: Biotech assets & discovery platforms Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D. March 3, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Best in Biotech 28 Feb 2025 Rare Disease Day: seven drugs awaiting approval in 2025 As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in 2025. February 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 28 Feb 2025The TCR-T cell therapies of tomorrow Sweden’s fastest growing private biotech, Anocca, is making plans for clinical trials in pancreatic cancer, with TCR-T cell therapy trials. February 28, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 27 Feb 2025 Eight respiratory disease companies advancing innovative therapies in 2025 Discover eight respiratory disease companies advancing their novel therapies through clinical trials in 2025. February 27, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Feb 2025 New non-opioid pain medication: How is the biotech industry fighting pain after the opioid crisis? Find out how biotechs are fighting pain with new non-opioid pain medication, as they look to overcome the ongoing opioid crisis. February 26, 2025 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Feb 2025 Seven biotech spinouts to watch out for in 2025 Here are seven biotech spinouts to keep an eye out for this year that specialize in a number of therapeutic areas. February 25, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Collaborative Drug Discovery Inc. 25 Feb 2025 How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for neurodegenerative diseases. February 25, 2025 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2025 Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree? This year has seen Eli Lilly sign several licensing deals to bolster its position across a range of therapeutic areas amid growing drug revenues. February 24, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 21 Feb 2025 The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells Discover how biotech could solve the organ shortage crisis through xenotransplantation, 3D bioprinting and stem cells. February 21, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email